{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:13:08Z","timestamp":1790439188113,"version":"4.1.0"},"reference-count":49,"publisher":"The Company of Biologists","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"am","delay-in-days":3059,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Mutations in the superoxide dismutase gene (SOD1) are one cause of familial amyotrophic lateral sclerosis [ALS; also known as motor neuron disase (MND)] in humans. ALS is a relentlessly progressive neurodegenerative disease and, to date, there are no neuroprotective therapies with significant impact on the disease course. Current transgenic murine models of the disease, which overexpress mutant SOD1, have so far been ineffective in the identification of new therapies beneficial in the human disease. Because the human and the zebrafish (Danio rerio) SOD1 protein share 76% identity, TILLING ('targeting induced local lesions in genomes') was carried out in collaboration with the Sanger Institute in order to identify mutations in the zebrafish sod1 gene. A T70I mutant zebrafish line was characterised using oxidative stress assays, neuromuscular junction analysis and motor function studies. A T70I mutant zebrafish line was characterised using oxidative stress assays, neuromuscular junction (NMJ) analysis and motor function studies. The T70I sod1 zebrafish model offers the advantage over current murine models of expressing the mutant Sod1 protein at a physiological level, as occurs in humans with ALS. The T70I sod1 zebrafish demonstrates key features of ALS; an early NMJ phenotype, a susceptibility to oxidative stress and an adult-onset motor neuron disease phenotype. We have demonstrated that the susceptibility of T70I sod1 embryos to oxidative stress can be used in a drug screening assay, to identify compounds that merit further investigation as potential therapies for ALS.<\/jats:p>","DOI":"10.1242\/dmm.012013","type":"journal-article","created":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T00:49:20Z","timestamp":1380761360000},"source":"Crossref","is-referenced-by-count":46,"title":["A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for <i>in vivo<\/i> therapeutic screening"],"prefix":"10.1242","author":[{"given":"Marc M. J.","family":"Da Costa","sequence":"first","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Allen","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Higginbottom","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tennore","family":"Ramesh","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2013,1,1]]},"reference":[{"key":"2021042513052777300_b1-0070073","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ana.10369","article-title":"True","volume":"52","author":"Alexander","year":"2002","journal-title":"Ann. Neurol."},{"key":"2021042513052777300_b2-0070073","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/120.10.1723","article-title":"Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia","volume":"120","author":"Andersen","year":"1997","journal-title":"Brain"},{"key":"2021042513052777300_b3-0070073","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative stress in ALS: key role in motor neuron injury and therapeutic target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"2021042513052777300_b4-0070073","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","article-title":"Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target","volume":"1762","author":"Barber","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042513052777300_b5-0070073","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.freeradbiomed.2009.01.019","article-title":"An in vitro screening cascade to identify neuroprotective antioxidants in ALS","volume":"46","author":"Barber","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"2021042513052777300_b6-0070073","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0003-2697(71)90370-8","article-title":"Superoxide dismutase: improved assays and an assay applicable to acrylamide gels","volume":"44","author":"Beauchamp","year":"1971","journal-title":"Anal. Biochem."},{"key":"2021042513052777300_b7-0070073","doi-asserted-by":"crossref","first-page":"7837","DOI":"10.1523\/JNEUROSCI.2420-04.2004","article-title":"L1.1 is involved in spinal cord regeneration in adult zebrafish","volume":"24","author":"Becker","year":"2004","journal-title":"J. Neurosci."},{"key":"2021042513052777300_b8-0070073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2006.12.015","article-title":"Lost in translation: treatment trials in the SOD1 mouse and in human ALS","volume":"26","author":"Benatar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"2021042513052777300_b9-0070073","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzole in amyotrophic lateral sclerosis","volume":"330","author":"Bensimon","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"2021042513052777300_b10-0070073","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1093\/hmg\/ddp310","article-title":"Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects","volume":"18","author":"Boon","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"2021042513052777300_b11-0070073","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.107.123000","article-title":"Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis","volume":"322","author":"Bordet","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2021042513052777300_b12-0070073","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma \u00d7 spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev. Dyn."},{"key":"2021042513052777300_b13-0070073","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cne.20111","article-title":"Cholinergic elements in the zebrafish central nervous system: Histochemical and immunohistochemical analysis","volume":"474","author":"Clemente","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"2021042513052777300_b14-0070073","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1471-4159.1998.70020501.x","article-title":"Peroxynitrite and hydrogen peroxide induced cell death in the NSC34 neuroblastoma \u00d7 spinal cord cell line: role of poly (ADP-ribose) polymerase","volume":"70","author":"Cookson","year":"1998","journal-title":"J. Neurochem."},{"key":"2021042513052777300_b15-0070073","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/146608202760196048","article-title":"Cu\/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress","volume":"3","author":"Cookson","year":"2002","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"2021042513052777300_b16-0070073","first-page":"1271","article-title":"Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis","volume":"145","author":"Dal Canto","year":"1994","journal-title":"Am. J. Pathol."},{"key":"2021042513052777300_b17-0070073","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"2021042513052777300_b18-0070073","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","article-title":"Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models","volume":"9","author":"Dupuis","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"2021042513052777300_b19-0070073","doi-asserted-by":"crossref","first-page":"e5390","DOI":"10.1371\/journal.pone.0005390","article-title":"Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons","volume":"4","author":"Dupuis","year":"2009","journal-title":"PLoS ONE"},{"key":"2021042513052777300_b20-0070073","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrneurol.2011.152","article-title":"Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis","volume":"7","author":"Ferraiuolo","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"2021042513052777300_b21-0070073","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"2021042513052777300_b22-0070073","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbadis.2010.10.012","article-title":"Investigating regeneration and functional integration of CNS neurons: lessons from zebrafish genetics and other fish species","volume":"1812","author":"Fleisch","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042513052777300_b23-0070073","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","article-title":"Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial","volume":"6","author":"Gordon","year":"2007","journal-title":"Lancet Neurol."},{"key":"2021042513052777300_b24-0070073","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat. Genet."},{"key":"2021042513052777300_b25-0070073","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/hmg\/ddp534","article-title":"Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo","volume":"19","author":"Kabashi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021042513052777300_b26-0070073","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbadis.2010.09.011","article-title":"Zebrafish models for the functional genomics of neurogenetic disorders","volume":"1812","author":"Kabashi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042513052777300_b27-0070073","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbr.2010.04.042","article-title":"Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS)","volume":"213","author":"Knippenberg","year":"2010","journal-title":"Behav. Brain Res."},{"key":"2021042513052777300_b28-0070073","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"2021042513052777300_b29-0070073","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/hmg\/ddm193","article-title":"Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish","volume":"16","author":"Lemmens","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"2021042513052777300_b30-0070073","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","article-title":"Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations","volume":"61","author":"Mackenzie","year":"2007","journal-title":"Ann. Neurol."},{"key":"2021042513052777300_b31-0070073","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/74542","article-title":"Targeted screening for induced mutations","volume":"18","author":"McCallum","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"2021042513052777300_b32-0070073","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.freeradbiomed.2013.04.018","article-title":"S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis","volume":"61","author":"Mead","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"2021042513052777300_b33-0070073","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/brain\/awf167","article-title":"Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis","volume":"125","author":"Menzies","year":"2002","journal-title":"Brain"},{"key":"2021042513052777300_b34-0070073","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1523\/JNEUROSCI.06-08-02278.1986","article-title":"Development and axonal outgrowth of identified motoneurons in the zebrafish","volume":"6","author":"Myers","year":"1986","journal-title":"J. Neurosci."},{"key":"2021042513052777300_b35-0070073","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-5793(95)00084-M","article-title":"Unique molecular properties of superoxide dismutase from teleost fish skin","volume":"360","author":"Nakano","year":"1995","journal-title":"FEBS Lett."},{"key":"2021042513052777300_b36-0070073","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1073\/pnas.0812046106","article-title":"Functional features cause misfolding of the ALS-provoking enzyme SOD1","volume":"106","author":"Nordlund","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042513052777300_b37-0070073","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/hmg\/ddq202","article-title":"ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2","volume":"19","author":"Pedrini","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2021042513052777300_b38-0070073","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1242\/dmm.005538","article-title":"A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease","volume":"3","author":"Ramesh","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"2021042513052777300_b39-0070073","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","article-title":"Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury","volume":"13","author":"Reaume","year":"1996","journal-title":"Nat. Genet."},{"key":"2021042513052777300_b40-0070073","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"2021042513052777300_b41-0070073","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"2021042513052777300_b42-0070073","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/mus.20495","article-title":"Clinicopathological phenotype of ALS with a novel G72C SOD1 gene mutation mimicking a myopathy","volume":"33","author":"Stewart","year":"2006","journal-title":"Muscle Nerve"},{"key":"2021042513052777300_b43-0070073","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbadis.2010.10.011","article-title":"Behavioural assessments of neurotoxic effects and neurodegeneration in zebrafish","volume":"1812","author":"Tierney","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042513052777300_b44-0070073","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1073\/pnas.93.7.3155","article-title":"Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions","volume":"93","author":"Tu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042513052777300_b45-0070073","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pneurobio.2008.01.001","article-title":"Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS","volume":"85","author":"Turner","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"2021042513052777300_b46-0070073","volume-title":"The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish","author":"Westerfield","year":"2000","edition":"4th"},{"key":"2021042513052777300_b47-0070073","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.1071762","article-title":"Target-selected inactivation of the zebrafish rag1 gene","volume":"297","author":"Wienholds","year":"2002","journal-title":"Science"},{"key":"2021042513052777300_b48-0070073","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1101\/gr.10.12.1903","article-title":"A comparative map of the zebrafish genome","volume":"10","author":"Woods","year":"2000","journal-title":"Genome Res."},{"key":"2021042513052777300_b49-0070073","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1101\/gr.4134305","article-title":"The zebrafish gene map defines ancestral vertebrate chromosomes","volume":"15","author":"Woods","year":"2005","journal-title":"Genome Res."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/7\/1\/73\/1866017\/73.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.012013\/2035803\/dmm_012013.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.012013\/2035803\/dmm_012013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T20:34:08Z","timestamp":1621370048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/doi\/10.1242\/dmm.012013\/258840\/A-new-zebrafish-model-produced-by-TILLING-of-SOD1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1242\/dmm.012013","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,1]]},"article-number":"dmm.012013"}}